European Journal of Clinical Pharmacology

Papers
(The TQCC of European Journal of Clinical Pharmacology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Understanding attitudes towards psychiatric medications: a comparative study of patients, healthcare professionals, and general population perspectives159
Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study77
Might chronic spontaneous urticaria develop after SARS-CoV-2 vaccinations?65
Oral Melatonin for Pain Relief During Venepuncture in Neonates– a Pilot Randomized Control Trial48
How to make the best of NLRP3 inhibitors in patients with COVID-19?41
Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis38
A Study Of the effect of Sex on drug dosing, concentrations, and pharmacogenomics in the Montreal Heart Institute Hospital Cohort (SOS-PGx): methodology and research progress36
Correction to: A real-world pharmacovigilance study of adverse events associated with esketamine: disproportionality analysis and detection of potential drug-drug interaction signals36
A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease33
Identification of novel signal of DRESS associated with antibiotics: a disproportionality analysis of the FDA adverse event reporting system (FAERS) database32
Lowering cyclosporine trough concentration threshold effectively mitigates acute graft-versus-host disease in children with severe β-Thalassemia post hematopoietic stem cell transplantation31
Usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study30
A systematic literature review of economic evaluations of setmelanotide29
Population pharmacokinetics and pharmacodynamics of meropenem in critically ill patients with renal impairment or on continuous renal replacement therapy29
Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study28
Beyond safety: adverse events and unanticipated advantages of SGLT2 inhibitors27
Incidence and risk factors of drug-induced kidney injury in children: a systematic review and meta-analysis27
Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials26
The Effect of the combination therapy of statin and dapagliflozin, a selective inhibitor of sodium_glucose Co-transporter type 2, in the treatment of Ischemic heart disease with heart failure: A rando26
The efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with left-sided bioprosthetic heart valves and atrial fibrillation: a systematic review and meta-analysis25
Physicians’ gender and specialty in relation to adverse drug reaction reporting in Sweden22
Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers22
Comment on “Use of statins and risks of ovarian, uterine, and cervical diseases: a cohort study in the UK Biobank”22
Challenges of pediatric pharmacotherapy: A narrative review of pharmacokinetics, pharmacodynamics, and pharmacogenetics21
Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety data21
Association of high risk of liver fibrosis in patients with serious outcomes of adverse drug reactions21
Clinical pharmacology—how it shapes the drug development journey21
Economic evaluation of antibody-drug conjugates (ADCs) in patients with breast cancer: systematic review21
Response to comment on “The role of prescribed opioids in Norwegian overdose deaths in 2005–2021”20
Trimetazidine and allopurinol for the prevention of Contrast-associated acute kidney injury in elective percutaneous coronary intervention: a randomized controlled trial20
Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service—a cross-sectional study of patients in a Canadian Health Region20
Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation19
Purine xanthine oxidase inhibitors are not conducive to the prognosis of chronic heart failure: a meta-analysis19
Relationship between CYP2C8, UGT1A1, and ABCG2 gene polymorphisms and the exposure, efficacy, and toxicity of eltrombopag in the treatment of refractory aplastic anemia19
Patient involvement in pharmacovigilance: determinants and evolution of reporting from 2011 to 2020 in France19
Oral mannitol for bowel preparation: a dose-finding phase II study18
Impact of eGFR estimation methods on drug dosing in pediatric ICU: a study of serum creatinine vs. cystatin C18
Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis18
Effectiveness and safety of concomitant use of direct oral anticoagulants and antiarrhythmic drugs: a systematic review of observational studies18
Clinical pharmacokinetics and pharmacodynamics of ivosidenib in Chinese patients with relapsed or refractory IDH1-mutated acute myeloid leukemia18
Disproportionality analysis from World Health Organization data on migraine-specific medications and cerebrovascular diseases18
The contribution of genotype-guided selection of P2Y12 inhibitor on prognosis in ACS /CCS patients undergoing percutaneous coronary intervention: a retrospective cohort study18
Anticoagulants in adult extracorporeal membrane oxygenation: alternatives to standardized anticoagulation with unfractionated heparin18
Effect of dapagliflozin on malignant ventricular arrhythmias in elderly after acute myocardial infarction: a propensity score-matched cohort study18
Retrospective review of intermittent and continuous infusion vancomycin for methicillin-resistant Staphylococcus aureus bacteremia17
Construction and temporal external validation of interpretable machine-learning models for predicting tigecycline-associated hypofibrinogenemia17
Effect of timing of administration on lipid-lowering efficacy of statins-meta-analysis17
Challenging the young and shaping the growth of clinical pharmacology: 10 years of the EACPT Early Career Clinical Pharmacologists (ECCP) working group17
Simulation of Imatinib Pharmacokinetics in pregnant women with chronic myeloid leukemia in the third trimester16
Cost-effectiveness of sofosbuvir- ledipasvir for Hepatitis C treatment: a systematic review16
Cost-effectiveness of abortive and preventative treatments in patients with migraine: a systematic review16
Dose reduction and discontinuation due to the combination of CDK4/6 inhibitors and endocrine drugs: a systematic review and meta-analysis16
Activities of clinical pharmacologists across Europe: A survey by the European association of clinical pharmacology and therapeutics15
ChatGPT for generating multiple-choice questions: comment15
Rating scales to measure adverse effects of medications in people with intellectual disability: a scoping review15
Cardiovascular medications used for comorbid diseases in patients with atrial fibrillation. The JoFib study15
Correction to: Analgesic effect of oral paracetamol 1000 mg/ibuprofen 400 mg, paracetamol 1000 mg/codeine 60 mg, paracetamol 1000 mg/ibuprofen 400 mg/codeine 60 mg, or placebo on acute postoperative p14
Analgesic potential of transdermal nicotine patch in surgery: a systematic review and meta-analysis of randomised placebo-controlled trials14
Voriconazole therapeutic drug monitoring including analysis of CYP2C19 phenotype in immunocompromised pediatric patients with invasive fungal infections14
A cocktail probe approach to evaluate the effect of hormones on the expression and activity of CYP enzymes in human hepatocytes with conditions simulating late stage of pregnancy14
Correction to: The risk of congenital heart defects associated with corticosteroids use during the first trimester of pregnancy: a systematic review and meta‑analysis14
Posting of clinical trial results and other critical information from completed medicines trials on ClinicalTrials.gov14
Abuse, dependence and withdrawal associated with fentanyl and the role of its (designated) route of administration: an analysis of spontaneous reports from Europe13
Efficacy of tacrolimus versus cyclosporine after lung transplantation: an updated systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials13
Statin treatment for primary and secondary prevention in elderly patients—a cross-sectional study in Stockholm, Sweden13
Exploring heterogeneities of cardiovascular efficacy and effectiveness of SGLT2 inhibitors in patients with type 2 diabetes: an umbrella review of evidence from randomized clinical trials versus real-13
The beneficial use of nitric oxide during cardiopulmonary bypass on postoperative outcomes in children and adult patients: a systematic review and meta-analysis of 2897 patients13
Proton pump inhibitor use: systematic review of global trends and practices13
Correction to: Adherence to psychotropic medication in completed suicide in Sweden 2006–2013: a forensic-toxicological matched case-control study13
Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis13
Evaluating the safety and effectiveness of tolvaptan in patients with heart failure and renal impairment: a systematic review and meta-analysis12
Tramadol and the risk of bleeding complications in patients on oral anticoagulants: a pharmacovigilance study12
Effectiveness and safety of vonoprazan-based regimens compared with those of proton pump inhibitor (PPI)–based regimens as first-line agents for Helicobacter pylori: a meta-analysis of randomized clin12
Assessment of severity and avoidability of adverse drug reactions in neonates: a reproducibility study of the Hartwig tool and LAAT12
ChatGPT for generating multiple-choice questions: Evidence on the use of artificial intelligence in automatic item generation for a rational pharmacotherapy exam12
Imatinib pharmacokinetics and creatine kinase levels in chronic myeloid leukemia patients: implications for therapeutic response and monitoring12
Grade ≥ 3 hematologic adverse events of immunotherapy in advanced NSCLC patients: a systematic review and meta-analysis12
Mechanisms of landiolol-mediated positive inotropy in critical care settings12
Proton pump inhibitors and gastric or colorectal cancer: a real-world safety analysis in the global pharmacovigilance database12
Peripheral edema induced by isosorbide mononitrate in an elderly patient: A case study of dose-related risks and drug interactions12
Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study11
Tool use isn’t enough—outcomes matter11
No evidence of clinical efficacy of oxomemazine in cough, according to a systematic review11
Guideline-directed heart failure pharmacotherapy and depression/anxiety: a scoping review of heart failure and related cardiovascular populations11
From empirical caution to precision resumption: model-informed management of a binimetinib overdose in a frail elderly patient11
Will artificial intelligence chatbots replace clinical pharmacologists? An exploratory study in clinical practice11
GLP 1 receptor agonists and obesity-associated cancers: a disproportionality analysis in Vigibase®11
Spikevax booster and delayed urticaria: a Swiss signal with diagnostic uncertainties due to a high proportion of direct patient reports11
Pharmacotherapy of Alzheimer’s disease: an overview of systematic reviews11
A novel physiologically-based pharmacokinetic model to estimate reduced CYP3A4 activity in cancer patients utilizing the neutrophil-to-lymphocyte ratio as an inflammatory marker11
Estimated equipotent conversion ratios of morphine, sufentanil and fentanyl as continuous infusion in neonatal intensive care units: a pharmacoepidemiologic cohort study10
Effect of metoprolol exposure following myocardial infarction on future cardiovascular events: a Mendelian randomization study10
Effects of renal impairment on the pharmacokinetics, safety, and tolerability of pudexacianinium (ASP5354) after IV administration: a mechanistic exploration10
Could carbamazepine-acetazolamide interaction lead to a severe hepatocellular liver injury? an interaction that needs to be uncovered10
Analgesic effect of oral paracetamol 1000 mg/ibuprofen 400 mg, paracetamol 1000 mg/codeine 60 mg, paracetamol 1000 mg/ibuprofen 400 mg/codeine 60 mg, or placebo on acute postoperative pain: a single-d10
Early albumin infusion and mortality in ICU patients with HFpEF: a target trial emulation study10
Risk factors for thrombocytopenia in patients receiving linezolid therapy: a systematic review and meta-analysis10
Correction to: Use of antibiotics in the early COVID‑19 pandemic in Poland, the Netherlands and Spain, from erraticism to (more) logic10
ChatGPT for generating multiple-choice questions: a reply10
Prescribed drugs and comorbidities as risk factors for Torsades de Pointes arrhythmia: a Swedish population-based cohort study10
Nitrofurantoin for the treatment of uncomplicated urinary tract infection in female patients: the impact of dosing regimen, age, and renal function on drug exposure10
Clinical and biochemical characteristics, and outcome in 33 patients with ceftriaxone-induced liver injury9
Tacrolimus improved the pregnancy outcomes of patients with refractory recurrent spontaneous abortion and immune bias disorders: a randomized controlled trial9
Perception of pharmacological equivalence of generics or biosimilars in healthcare professionals in Vienna9
The Scottish medicines in pregnancy programme: supporting the surveillance of medicines use during pregnancy and assessment of associated clinical outcomes9
Facilitators and barriers to generic and biosimilar medications in the Middle East and North Africa: insights from physicians and pharmacists—a systematic review9
Oxytocin treatment for core symptoms in children with autism spectrum disorder: a systematic review and meta-analysis9
Teaching rational prescribing in undergraduate medical education: a systematic search and review9
Relating consequential falls to individual and combinations of prescription medication use in Swedish older adults9
Clozapine prescribing in treatment-resistant schizophrenia – an updated systematic literature review of barriers and facilitators among clinicians9
The impact of denosumab and calcitriol on asthma risk and lung function: a drug target mendelian randomization study9
Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study)9
Delayed gastric emptying and antiseizure medication absorption: a potential pharmacokinetic consideration for GLP-1/GIP receptor agonists9
A standard dose of linezolid puts patients with hepatic impairment at risk of overexposure9
Systematic review and first meta-analysis of the efficacy and safety of gemcitabine-cisplatin combined with paclitaxel in patients with advanced biliary tract cancer9
Patterns of inappropriate prescribing and clinical characteristics in patients at admission to an acute care of the elderly unit9
Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignancies9
Comment on “CYP2C19 genotyping and mavacamten: predicting outcomes in normal, intermediate and rapid metabolisers in obstructive hypertrophic cardiomyopathy”9
Why we should not recommend or offer fluvoxamine to COVID-19 patients?8
Pharmacological interventions for preventing atrial fibrillation after lung surgery: systematic review and meta-analysis8
Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benef8
Does evidence from RCTs suggest: SGLT2 inhibitors could not reduce myocardial infarction and stroke?8
Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings8
Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers8
Estimating the impact of label design on reducing the risk of medication errors by applying HEART in drug administration8
Comment on “Prescribing patterns of glucagon like peptide-1 receptor agonists in the Swedish capital region: a register-based cross-sectional study”8
A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization – results from IQVIA™ Disease Analyzer Germany8
Dose-dependent efficacy and safety of Filgotinib in moderate to severe Crohn’s disease: a grade-assessed systematic review and meta-analysis of randomized controlled trials8
Effect of transporter gene polymorphisms and valproate co-medication on the steady-state disposition of lamotrigine and their effect on efficacy in adults with epilepsy8
Perception of clinical research among patients and healthy volunteers of clinical trials8
Optimization of vitamin K antagonist treatment: Near patient monitoring versus standard of care a parallel group clinical trial in older patients with atrial fibrillation8
Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis8
Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials i8
Therapeutic drug monitoring as an essential tool to ensure clozapine efficacy and prevent its toxicity in smokers: a case report8
Comparison between clopidogrel and ticagrelor in CYP2C19 loss-of-function alleles coronary artery disease and stroke patients: a meta-analysis8
Circadian considerations in antimicrobials8
Population pharmacokinetics of bedaquiline: a systematic review8
Efficacy and safety of nitazoxanide and escitalopram as adjuvant therapies in patients with rheumatoid arthritis: a randomized controlled study8
Non-persistence to antihypertensive drug therapy in Lithuania8
The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study8
Serum trough concentration threshold and risk factors of cefoperazone-induced coagulopathy in critically ill patients: A retrospective case-control study8
Approaches for posaconazole therapeutic drug monitoring and their clinical benefits7
Impact of tofogliflozin on hepatic outcomes: a systematic review7
Comment on: “Genome-wide association study of direct oral anticoagulants and their relation to bleeding”7
Predictive Role of Serotonin Receptor (5HTR2A) and Dopamine Receptor (DRD2) gene polymorphisms in risperidone-induced weight gain and hyperprolactinemia in patients with schizophrenia7
Influence of antihypertensive drug classes on circadian blood pressure patterns and left ventricular remodeling - a retrospective study7
Relationship between elevated bilirubin levels and enhanced warfarin effects during biliary obstruction7
Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range7
Drug supply shortages and their perceived consequences for patients: a questionnaire survey of German and Austrian physicians7
Hospitalisations related to benzodiazepine, Z-drug, and opioid treatment in Italy: a claim on the risks associated with inappropriate use7
Influence of metformin on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials7
A real-world pharmacovigilance study of adverse events associated with esketamine: disproportionality analysis and detection of potential drug-drug interaction signals7
Response commentary: the effect of colchicine on coagulation in patients with chronic coronary disease who use vitamin K antagonists7
Association between antidepressant use and gynecological cancer risk: a systematic review and meta-analysis7
Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients7
Effectiveness of treatments for propranolol toxicity: a systematic review of current approaches and evidence7
Exploring potential biomarkers and constructing prediction models of osimertinib based on a retrospective study7
Characteristics of isoniazid-induced psychosis: a systematic review of case reports and case series7
Written drug promotion from pharmaceutical companies to general practitioners: adherence to regulations over two decades7
A meta-analysis and systematic review of the first Trop-2-targeting antibody–drug conjugate (sacituzumab govitecan) in treating metastatic breast cancer7
Inhalation therapies in COPD — adverse drug reactions impact on emergency department presentations7
High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease7
15th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT)7
Author’s reply to the letter to the editor: “Effects of dapagliflozin and empagliflozin on 6‑min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and me7
Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials7
Pharmacogenetics of opioid medications for relief of labor pain and post-cesarean pain: a systematic review and meta-analysis7
Coenzyme Q10 as a potential add-on treatment for patients suffering from painful diabetic neuropathy: results of a placebo-controlled randomized trial7
Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivo7
Efficacy and safety of CGRP monoclonal antibodies for migraine prevention in episodic migraine; a network Meta-analysis6
Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis6
Efficacy of botulinum toxin type a for treating chronic low back pain: a systematic review and metanalysis6
Validating the accuracy of mathematical model–based pharmacogenomics dose prediction with real-world data6
Optimisation of warfarin-dosing algorithms for Han Chinese patients with CYP2C9*13 variants6
Population pharmacokinetics of rivaroxaban after transjugular intrahepatic portosystemic shunt6
Effects of oral antidiabetic agents on the renin–angiotensin–aldosterone system6
Trends in ADR reporting’ and the missing context: COVID-19, LMICs, and sociodemographic blind spots6
Letter to the editor: "Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis of randomi6
Time-dependent association between omeprazole and esomeprazole and hospitalization due to hyponatremia6
Long-term results of a multidisciplinary medication optimization program for older adults including primary care and hospital team6
Effects of mirabegron on brown adipose tissue and metabolism in humans: A systematic review and meta-analysis6
Efficacy and safety of different pharmacological interventions in the treatment of tardive dyskinesia: a systematic review and network meta-analysis6
Comparative effectiveness and safety of non–vitamin K antagonist oral anticoagulant-based triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous c6
Innovative applications of artificial intelligence technology in pharmacometrics6
Area under the curve of tacrolimus using microsampling devices: towards precision medicine in solid organ transplantation?6
The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer6
Educational value of international and intercultural differences in prescribing: the international and interprofessional student-run clinic project6
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study6
Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review6
COVID-19 and pregnancy: A European study on pre- and post-infection medication use6
Correction to: Potentially inappropriate medications and cognitive performance: cross‑sectional results from the ELSA–Brasil study6
The safety and efficacy of bevacizumab in treatment of recurrent low-grade glioma: a systematic review and meta-analysis6
ACD856, a novel positive allosteric modulator of Trk receptors, single ascending doses in healthy subjects: Safety and pharmacokinetics6
Influence of cigarette smoking on drugs’ metabolism and effects: a systematic review6
Duplicate prescriptions in the emergency department: a retrospective cohort study6
The efficacy and safety of pentoxifylline in the treatment of chronic kidney disease: a systematic review and meta-analysis6
Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate6
Pharmacokinetics-pharmacodynamics of first-line antitubercular drugs: a comparative study in tuberculosis patients with and without concomitant diabetes mellitus6
Era of surrogate endpoints and accelerated approvals: a comprehensive review on applicability, uncertainties, and challenges from regulatory, payer, and patient perspectives6
Use of pregabalin and limaprost in the conservative treatment of lumbar spinal stenosis: a systematic review of the current evidence6
Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis6
Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets6
0.12930202484131